aTYR PHARMA INC Quarterly Operating Income (Loss) in USD from Q1 2014 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: aTYR PHARMA INC quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q2 2024.
aTYR PHARMA INC Operating Income (Loss) for the quarter ending June 30, 2024 was -$17.3M, a 27.7% decline year-over-year.
aTYR PHARMA INC Operating Income (Loss) for the twelve months ending June 30, 2024 was -$62.5M, a 30.8% decline year-over-year.
aTYR PHARMA INC annual Operating Income (Loss) for 2023 was -$54.9M, a 18.4% decline from 2022.
aTYR PHARMA INC annual Operating Income (Loss) for 2022 was -$46.4M, a 36.4% decline from 2021.
aTYR PHARMA INC annual Operating Income (Loss) for 2021 was -$34M, a 114% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$62.5M	-$17.3M	-$3.76M	-27.7%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	-$58.8M	-$16.6M	-$3.85M	-30.1%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-02
Q4 2023	-$54.9M	-$16M	-$8.01M	-101%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-14
Q3 2023	-$46.9M	-$12.6M	+$877K	+6.5%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	-$47.8M	-$13.6M	-$974K	-7.74%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-13
Q1 2023	-$46.8M	-$12.8M	-$409K	-3.3%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-02
Q4 2022	-$46.4M	-$7.95M	+$690K	+7.99%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-14
Q3 2022	-$47.1M	-$13.5M	-$5.76M	-74.6%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	-$41.3M	-$12.6M	-$2.14M	-20.5%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-09
Q1 2022	-$39.2M	-$12.4M	-$5.18M	-71.9%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-09
Q4 2021	-$34M	-$8.64M	-$3.7M	-74.9%	Oct 1, 2021	Dec 31, 2021	10-K	2024-03-14
Q3 2021	-$30.3M	-$7.73M	-$1.22M	-18.7%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$29.1M	-$10.4M	-$4.13M	-65.3%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-15
Q1 2021	-$25M	-$7.2M	-$9.06M	-487%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-10
Q4 2020	-$15.9M	-$4.94M	+$1.02M	+17.1%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-14
Q3 2020	-$16.9M	-$6.51M	-$1.01M	-18.4%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-12
Q2 2020	-$15.9M	-$6.32M	-$677K	-12%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-11
Q1 2020	-$15.2M	$1.86M	+$7.74M		Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-14
Q4 2019	-$23M	-$5.96M	+$1K	+0.02%	Oct 1, 2019	Dec 31, 2019	10-K	2022-03-15
Q3 2019	-$23M	-$5.5M	+$1.18M	+17.7%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-13
Q2 2019	-$24.2M	-$5.64M	+$4.32M	+43.4%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-13
Q1 2019	-$28.5M	-$5.88M	+$4.34M	+42.5%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-12
Q4 2018	-$32.8M	-$5.96M	+$5.24M	+46.8%	Oct 1, 2018	Dec 31, 2018	10-K	2021-03-24
Q3 2018	-$38.1M	-$6.68M	+$4.15M	+38.3%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-14
Q2 2018	-$42.2M	-$9.96M	+$1.95M	+16.4%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-14
Q1 2018	-$44.2M	-$10.2M	+$2.99M	+22.6%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-14
Q4 2017	-$47.1M	-$11.2M	+$1.33M	+10.6%	Oct 1, 2017	Dec 31, 2017	10-K	2020-03-26
Q3 2017	-$48.5M	-$10.8M	+$3.04M	+21.9%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-14
Q2 2017	-$51.5M	-$11.9M	+$3.53M	+22.8%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-14
Q1 2017	-$55M	-$13.2M	+$2.9M	+18%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-15
Q4 2016	-$57.9M	-$12.5M	+$3.96M	+24%	Oct 1, 2016	Dec 31, 2016	10-K	2019-03-26
Q3 2016	-$61.9M	-$13.9M	-$2.55M	-22.6%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-14
Q2 2016	-$59.3M	-$15.4M	-$4.54M	-41.6%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-14
Q1 2016	-$54.8M	-$16.1M	-$7.19M	-80.6%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-11
Q4 2015	-$47.6M	-$16.5M	-$10.5M	-173%	Oct 1, 2015	Dec 31, 2015	10-K	2018-03-20
Q3 2015	-$37.2M	-$11.3M	-$5.08M	-81.6%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-14
Q2 2015	-$32.1M	-$10.9M	-$5.54M	-103%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-10
Q1 2015	-$26.5M	-$8.92M	-$2.99M	-50.5%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-11
Q4 2014	-$23.6M	-$6.03M			Oct 1, 2014	Dec 31, 2014	10-K	2017-03-16
Q3 2014		-$6.23M			Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-10
Q2 2014		-$5.36M			Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-12
Q1 2014		-$5.93M			Jan 1, 2014	Mar 31, 2014	10-Q	2015-06-18

* An asterisk sign (*) next to the value indicates that the value is likely invalid.